Chelerythrine stimulates GSH transport by rat Mrp2 (Abcc2) expressed in canine kidney cells

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 285, Issue 6 48-6, 2003, Pages

  Lou, Huan ^a   Ookhtens, Murad ^a   Stolz, Andrew ^a   Kaplowitz, Neil ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Glutathione conjugates; Glutathione chelerythrine adduct; Membrane transport; Membrane vesicles; Polarized cells

Indexed keywords

CHELERYTHRINE; GLUTATHIONE; MULTIDRUG RESISTANCE PROTEIN 2;

ANIMAL CELL; ARTICLE; CELL MEMBRANE TRANSPORT; CONTROLLED STUDY; IC 50; KIDNEY CELL; MEMBRANE VESICLE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STOICHIOMETRY;

EID: 0344063596     PISSN: 01931857     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpgi.00271.2003     Document Type: Article

References (40)

1. Balboa MA and Insel PA. Stimulation of phospholipase D via alpha1-adrenergic receptors in Madin-Darby canine kidney cells is independent of PKCalpha and -epsilon activation. Mol Pharmacol 53: 221-227, 1998.
2. Bentley KW. Beta-phenylethylamines and the isoquinoline alkaloids. Nat Prod Rep 18: 148-170, 2001.
3. Borst P, Evers R, Kool M, and Wijnholds J. The multidrug resistance protein family. Biochim Biophys Acta 1461: 347-357, 1999.
4. Boyer JL and Meier PJ. Characterizing mechanisms of hepatic bile acid transport utilizing isolated membrane vesicles. Methods Enzymol 192: 517-533, 1990.
5. Chen ZS, Kawabe T, Ono M, Aoki S, Sumizawa T, Furukawa T, Uchiumi T, Wada M, Kuwano M, and Akiyama SI. Effect of multidrug resistance-reversing agents on transporting activity of human canalicular multispecific organic anion transporter. Mol Pharmacol 56: 1219-1228, 1999.
6. Cui Y, Konig J, Buchholz JK, Spring H, Leier I, and Keppler D. Drug resistance and ATP-dependent conjugate transport mediated by the apical multidrug resistance protein, MRP2, permanently expressed in human and canine cells. Mol Pharmacol 55: 929-937, 1999.
7. Da Costa SR, Yarber FA, Zhang L, Sonee M, and Hamm-Alvarez SF. Microtubules facilitate the stimulated secretion of beta-hexosaminidase in lacrimal acinar cells. J Cell Sci 111: 1267-1276, 1998.
8. Davies SP, Reddy H, Caivano M, and Cohen P. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J 351: 95-105, 2000.
9. Dietrich CG, Ottenhoff R, de Waart DR, and Oude Elferink RP. Role of MRP2 and GSH in intrahepatic cycling of toxins. Toxicology 167: 73-81, 2001.
10. Elferink RP, Ottenhoff R, Liefting W, de Haan J, and Jansen PL. Hepatobiliary transport of glutathione and glutathione conjugate in rats with hereditary hyperbilirubinemia. J Clin Invest 84: 476-483, 1989.
11. Evers R, de Haas M, Sparidans R, Beijnen J, Wielinga PR, Lankelma J, and Borst P. Vinblastine and sulfinpyrazone export by the multidrug resistance protein MRP2 is associated with glutathione export. Br J Cancer 83: 375-383, 2000.
12. Evers R, Kool M, van Deemter L, Janssen H, Calafat J, Oomen LC, Paulusma CC, Oude Elferink RP, Baas F, Schinkel AH, and Borst P. Drug export activity of the human canalicular multispecific organic anion transporter in polarized kidney MDCK cells expressing cMOAT (MRP2) cDNA. J Clin Invest 101: 1310-1319, 1998.
13. Fariss MW and Reed DJ. High-performance liquid chromatography of thiols and disulfides: dinitrophenol derivatives. Methods Enzymol 143: 101-109, 1987.
14. Fernandez-Checa JC, Takikawa H, Horie T, Ookhtens M, and Kaplowitz N. Canalicular transport of reduced glutathione in normal and mutant Eisai hyperbilirubinemic rats. J Biol Chem 267: 1667-1673, 1992.
15. Fuller S, von Bonsdorff CH, and Simons K. Vesicular stomatitis virus infects and matures only through the basolateral surface of the polarized epithelial cell line, MDCK. Cell 38: 65-77, 1984.
16. Ito K, Suzuki H, Hirohashi T, Kume K, Shimizu T, and Sugiyama Y. Molecular cloning of canalicular multispecific organic anion transporter defective in EHBR. Am J Physiol Gastrointest Liver Physiol 272: G16-G22, 1997.
17. Kala SV, Neely MW, Kala G, Prater CI, Atwood DW, Rice JS, and Lieberman MW. The MRP2/cMOAT transporter and arsenic-glutathione complex formation are required for biliary excretion of arsenic. J Biol Chem 275: 33404-33408, 2000.
18. Kaplowitz N, Eberle DE, Petrini J, Touloukian J, Corvasce MC, and Kuhlenkamp J. Factors influencing the efflux of hepatic glutathione into bile in rats. J Pharmacol Exp Ther 224: 141-147, 1983.
19. Keppler D, Jedlitschky G, and Leier I. Transport function and substrate specificity of multidrug resistance protein. Methods Enzymol 292: 607-616, 1998.
20. Kerry MA, Duval O, Waigh RD, and Mackay SP. The role of the iminium bond in the inhibition of reverse transcriptase by quaternary benzophenanthridines 1. J Pharm Pharmacol 50: 1307-1315, 1998.
21. Kinoshita S, Suzuki H, Ito K, Kume K, Shimizu T, and Sugiyama Y. Transfected rat cMOAT is functionally expressed on the apical membrane in Madin-Darby canine kidney (MDCK) cells. Pharm Res 15: 1851-1856, 1998.
22. Konig J, Nies AT, Cui Y, Leier I, and Keppler D. Conjugate export pumps of the multidrug resistance protein (MRP) family: localization, substrate specificity, and MRP2-mediated drug resistance. Biochim Biophys Acta 1461: 377-394, 1999.
23. Krane BD, Fagbule MO, and Shamma M. The benzophenanthridine alkaloids. J Nat Prod 47: 1-43, 1984.
24. Lee SK, Qing WG, Mar W, Luyengi L, Mehta RG, Kawanishi K, Fong HH, Beecher CW, Kinghorn AD, and Pezzuto JM. Angoline and chelerythrine, benzophenanthridine alkaloids that do not inhibit protein kinase C. J Biol Chem 273: 19829-19833, 1998.
25. Loe DW, Almquist KC, Deeley RG, and Cole SP. Multidrug resistance protein (MRP)-mediated transport of leukotriene C4 and chemotherapeutic agents in membrane vesicles. Demonstration of glutathione-dependent vincristine transport. J Biol Chem 271: 9675-9682, 1996.
26. r 190,000 multidrug resistance protein (MRP): evidence for cotransport with reduced glutathione. Cancer Res 58: 5130-5136, 1998.
27. Loe DW, Deeley RG, and Cole SP. Verapamil stimulates glutathione transport by the 190-kDa multidrug resistance protein 1 (MRP1). J Pharmacol Exp Ther 293: 530-538, 2000.
28. Mittur AV, Kaplowitz N, Kempner ES, and Ookhtens M. Novel properties of hepatic canalicular reduced glutathione transport revealed by radiation inactivation. Am J Physiol Gastrointest Liver Physiol 274: G923-G930, 1998.
29. Paulusma CC, Bosma PJ, Zaman GJ, Bakker CT, Otter M, Scheffer GL, Scheper RJ, Borst P, and Oude Elferink RP. Congenital jaundice in rats with a mutation in a multidrug resistance-associated protein gene. Science 271: 1126-1128, 1996.
30. Paulusma CC, van Geer MA, Evers R, Heijn M, Ottenhoff R, Borst P, and Oude Elferink RP. Canalicular multispecific organic anion transporter/multidrug resistance protein 2 mediates low-affinity transport of reduced glutathione. Biochem J 338: 393-401, 1999.
31. Rebbeor JF, Connolly GC, and Ballatori N. Inhibition of Mrp2- and Ycf1p-mediated transport by reducing agents: evidence for GSH transport on rat Mrp2. Biochim Biophys Acta 1559: 171-178, 2002.
32. Rebbeor JF, Connolly GC, Dumont ME, and Ballatori N. ATP-dependent transport of reduced glutathione in yeast secretory vesicles. Biochem J 334: 723-729, 1998.
33. Reinhart P, Harkrader R, Wylie R, Yewey G, and Van Horne KC. Sanguinarine levels in biological samples by high-performance liquid chromatography. J Chromatogr 570: 425-434, 1991.
34. Renes J, de Vries EG, Nienhuis EF, Jansen PL, and Muller M. ATP- and glutathione-dependent transport of chemotherapeutic drugs by the multidrug resistance protein MRP1. Br J Pharmacol 126: 681-688, 1999.
35. SAAM Institute. SAAM II User's Guide. Seattle, WA: University of Washington, 1994.
36. Seckarova P, Marek R, Dostal J, Dommisse R, and Esmans EL. Structural studies of benzophenanthridine alkaloid free bases by NMR spectroscopy. Magn Reson Chem 40: 147-152, 2002.
37. Van Aubel RA, Koenderink JB, Peters JG, Van Os CH, and Russel FG. Mechanisms and interaction of vinblastine and reduced glutathione transport in membrane vesicles by the rabbit multidrug resistance protein Mrp2 expressed in insect cells. Mol Pharmacol 56: 714-719, 1999.
38. Walterova D, Ulrichova Preininger V, Simanek V, Lenfeld J, and Lasovsky J. Inhibition of liver alanine aminotransferase activity by some benzophenanthridine alkaloids. J Med Chem 24: 1100-1103, 1981.
39. Wolff J and Knipling L. Antimicrotubule properties of benzophenanthridine alkaloids. Biochemistry 32: 13334-13339, 1993.
40. Yu R, Mandlekar S, Tan TH, and Kong AN. Activation of p38 and c-Jun N-terminal kinase pathways and induction of apoptosis by chelerythrine do not require inhibition of protein kinase C. J Biol Chem 275: 9612-9619, 2000.